| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
KIN001-244 |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |